Inactive Instrument

News Beigene Ltd Hong Kong S.E.

Equities

End-of-day quote Hong Kong S.E. Other stock markets
- ^HKD	-

May. 09	Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up	MT
May. 08	Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up	May. 08	MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	May. 08	MT
BeiGene's Q1 Loss Narrows as Revenue Rises	May. 08	MT
Earnings Flash (BGNE) BEIGENE Reports Q1 Revenue $752M	May. 08	MT
BeiGene Reports First Quarter 2024 Financial Results and Business Updates	May. 08	BU
BeiGene, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
BeiGene, Ltd. Anticipates Opening of Biologics Manufacturing Facility and Clinical R&D Center at the Princeton West Innovation Campus in Hopewell, New Jersey, in July 2024	May. 08	CI
Amgen Posts Higher 1Q Revenue, Swings to Loss	May. 02	DJ
BeiGene : Financial Information - Form 8-K	Apr. 26	PU
BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report	Apr. 26	BU
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting	Apr. 24	BU
Sector Update: Health Care Stocks Rise in Afternoon Trading	Apr. 23	MT
BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise	Apr. 23	MT
BeiGene Shares Rise 7% After European Approval of Tislelizumab Cancer Treatment	Apr. 23	DJ
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading	Apr. 23	MT
BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer	Apr. 23	MT
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer	Apr. 23	BU
BeiGene, Ltd. Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer	Apr. 23	CI
BeiGene to Award Shares Worth $15 Million to 11 Directors	Apr. 17	MT
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech	Apr. 11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Beigene Ltd Hong Kong S.E.

Equities

Summary

Filters